Condensed Consolidated Statements of Shareholders' Equity / Member's (Deficit) - USD ($) $ in Thousands	Total	Common Shares	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjustment Accumulated Deficit
Beginning balance (in shares) at Mar. 31, 2019		0
Beginning balance at Mar. 31, 2019	$ (390,258)	$ 0	$ (184,546)	$ (176,002)	$ (29,710)
Increase (Decrease) in Partners' Capital [Roll Forward]
Foreign currency translation, net of tax	1,837				1,837
Equity repurchases	(53)		(53)
Net income (loss)	(49,155)			(49,155)
Ending balance (in shares) at Jun. 30, 2019		0
Ending balance at Jun. 30, 2019	(437,629)	$ 0	(184,599)	(225,157)	(27,873)
Increase (Decrease) in Partners' Capital [Roll Forward]
Cumulative effects adjustment for ASU 2016-02 adoption	$ 961,497	$ 281	1,573,347	(594,026)	(18,105)	$ 306	$ 306
Beginning balance (in shares) at Mar. 31, 2020	280,853,040	280,853,000
Increase (Decrease) in Partners' Capital [Roll Forward]
Foreign currency translation, net of tax	$ (2,342)				(2,342)
Restricted stock units vested (in shares)		132,000
Restricted stock units vested	0
Restricted stock awards forfeited (in shares)		(88,000)
Restricted stock awards forfeited	0
Issuance of common stock related to employee stock purchase plan (in shares)		159,000
Issuance of common stock related to employee stock purchase plan	3,592		3,592
Share-based compensation	12,672		12,672
Equity repurchases	(13)		(13)
Cumulative effects adjustment for ASU 2016-02 adoption	988,577	$ 281	1,589,598	(580,855)	(20,447)
Net income (loss)	$ 12,865			12,865
Ending balance (in shares) at Jun. 30, 2020	281,055,994	281,056,000
Ending balance at Jun. 30, 2020	$ 988,577	$ 281	1,589,598	(580,855)	(20,447)
Increase (Decrease) in Partners' Capital [Roll Forward]
Cumulative effects adjustment for ASU 2016-02 adoption	$ 988,577	$ 281	$ 1,589,598	$ (580,855)	$ (20,447)